Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-12-001444
Filing Date
2012-02-01
Accepted
2012-02-01 16:33:02
Documents
2
Period of Report
2012-01-31

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 15651
2 LIMITED POWER OF ATTORNEY ex24sinskey.txt EX-24 4363
  Complete submission text file 0001179110-12-001444.txt   21387
Mailing Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139 617-441-1000
MERRIMACK PHARMACEUTICALS INC (Issuer) CIK: 0001274792 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O METABOLIX 21 ERIE STREET CAMBRIDGE MA 02139
Business Address
Sinskey Anthony J (Reporting) CIK: 0001368753 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35409 | Film No.: 12562939